Unger JM, Cook E, Tai E, Bleyer A. The role of clinical trial participation in cancer research: barriers, evidence, and strategies. Am Soc Clin Oncol Educ Book. 2016;36:185–98.
Unger JM, Vaidya R, Hershman DL, Minasian LM, Fleury ME. Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation. J Natl Cancer Inst. 2019;111(3):245–55.
Zullig LL, Fortune-Britt AG, Rao S, Tyree SD, Godley PA, Carpenter WR. Enrollment and racial disparities in cancer treatment clinical trials in North Carolina. N C Med J. 2016;77(1):52–8.
Hamel LM, Penner LA, Albrecht TL, Heath E, Gwede CK, Eggly S. Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer. Cancer Control. 2016;23(4):327–37.
Aizer AA, Wilhite TJ, Chen MH, Graham PL, Choueiri TK, Hoffman KE, et al. Lack of reduction in racial disparities in cancer- specific mortality over a 20- year period. Cancer. 2014;120(10):1532–9.
Chen MS Jr, Lara PN, Dang JH, Paterniti DA, Kelly K. Twenty years post- NIH revitalization act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials. Cancer. 2014;120:1091–6.
Langford A, Resnicow K, An L. Clinical trial awareness among racial/ethnic minorities in HINTS 2007: socio-demographic, attitudinal, and knowledge correlates. J Health Commun. 2010;15(sup3):92–101.
Ford ME, Siminoff LA, Pickelsimer E, Mainous AG, Smith DW, Diaz VA, et al. Unequal burden of disease, unequal participation in clinical trials: solutions from African American and Latino community members. Health Soc Work. 2013;38(1):29–38.
Napoles A, Cook E, Ginossar T, Knight KD, Ford ME. Applying a conceptual framework to maximize the participation of diverse populations in cancer clinical trials. In: Advances in cancer research, vol. 133: Academic Press; 2017. p. 77–94.
Salman A, Nguyen C, Lee YH, Cooksey-James T. A review of barriers to minorities’ participation in cancer clinical trials: implications for future cancer research. J Immigr Minor Health. 2016;18(2):447–53.
Clark LT, Watkins L, Piña IL, Elmer M, Akinboboye O, Gorham M, et al. Increasing diversity in clinical trials: overcoming critical barriers. Curr Probl Cardiol. 2019;44(5):148–72.
Ford JG, Howerton MW, Lai GY, Gary TL, Bolen S, Gibbons MC, et al. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer. 2008;112(2):228–42.
Freedman LS, Simon R, Foulkes MA, Friedman L, Geller NL, Gordon DJ, et al. Perspective of NIH clinical Trialists. Control Clin Trials. 1995;16:277–85.
Loree JM, Anand S, Dasari A, Unger JM, Gothwal A, Ellis LM, et al. Disparity of race reporting and representation in clinical trials leading to cancer drug approvals from 2008 to 2018. JAMA Oncol. 2019;5(10):e191870.
Deville C, Chapman CH, Burgos R, Hwang WT, Both S, Thomas CR Jr. Diversity by race, Hispanic ethnicity, and sex of the United States medical oncology physician workforce over the past quarter century. J Oncol Pract. 2014;10(5):e328–34.
Alsan M, Wanamaker M, Hardeman RR. The Tuskegee study of untreated syphilis: a case study in peripheral trauma with implications for health professionals. J Gen Intern Med. 2020;35(1):322–5.
Scharff DP, Mathews KJ, Jackson P, Hoffsuemmer J, Martin E, Edwards D. More than Tuskegee: understanding mistrust about research participation. J Health Care Poor Underserved. 2010;21(3):879.
Kaplan CP, Nápoles AM, Narine S, Gregorich S, Livaudais-Toman J, Nguyen T, et al. Knowledge and attitudes regarding clinical trials and willingness to participate among prostate cancer patients. Contemp Clin Trials. 2015;45:443–8.
Pariera KL, Murphy ST, Meng J, McLaughlin ML. Exploring willingness to participate in clinical trials by ethnicity. J Racial Ethn Health Disparities. 2017;4(4):763–9.
Zimet GD, Dahlem NW, Zimet SG, Farley GK. The multidimensional scale of perceived social support. J Pers Assess. 1988;52(1):30–41.
Shen L, Condit CM, Wright L. The psychometric property and validation of a fatalism scale. Psychol Health. 2009;24(5):597–613.
Luszczynska A, Scholz U, Schwarzer R. The general self-efficacy scale: multicultural validation studies. J Psychol. 2005;139(5):439–57.
Rustøen T, Lerdal A, Gay C, Kottorp A. Rasch analysis of the Herth Hope index in cancer patients. Health Qual Life Outcomes. 2018;16(1):196.
McCrum-Gardner E. Which is the correct statistical test to use? Br J Oral Maxillofac Surg. 2008;46(1):38–41.
U.S. Food and Drug Administration. 2018 Drug Trials Snapshots Summary Report. https://www.fda.gov/media/120253/download. Accessed 21 Oct 2020.
Hughes TB, Varma VR, Pettigrew C, Albert MS. African Americans and clinical research: evidence concerning barriers and facilitators to participation and recruitment recommendations. The Gerontologist. 2017;57(2):348–58.
Echeverri M, Anderson D, Nápoles AM, Haas JM, Johnson ME, Serrano FSA. Cancer health literacy and willingness to participate in cancer research and donate bio-specimens. Int J Environ Res Public Health. 2018;15(10):2019.
Swaby J, Kaninjing E, Ogunsanya M. African American participation in cancer clinical trials. Ecancermedicalscience. 2021;15:1307.
Haynes-Maslow L, Godley P, Dimartino L, White B, Odom J, Richmond A, et al. African American women’s perceptions of cancer clinical trials. Cancer Med. 2014;3(5):1430–9.
Evans KR, Lewis MJ, Hudson SV. The role of health literacy on African American and Hispanic/Latino perspectives on cancer clinical trials. J Cancer Educ. 2012;27(2):299–305.
Hernandez ND, Durant R, Lisovicz N, Nweke C, Belizaire C, Cooper D, et al. African American Cancer survivors’ perspectives on Cancer clinical trial participation in a safety-net hospital: considering the role of the social determinants of health. J Cancer Educ. 2021:1–9.
Ford M, Wahlquist A, Blake R, Green C, Streets J, Fuller E, et al. Assessing an intervention to improve clinical trial perceptions among predominately African- American communities in South Carolina. Prog Community Health Partnersh. 2012;6(3):249.
Banda DR, Libin AV, Wang H, Swain SM. A pilot study of a culturally targeted video intervention to increase participation of African American patients in cancer clinical trials. Oncologist. 2012;17(5):708–14.
Heiney, S. P., Adams, S. A., Wells, L. M., & Johnson, H. (2010). Evaluation of conceptual framework for recruitment of African American patients with breast cancer. In Oncology nursing forum (Vol. 37, no. 3, p. E160). NIH Public Access.
Fouad MN, Acemgil A, Bae S, Forero A, Lisovicz N, Martin MY, et al. Patient navigation as a model to increase participation of African Americans in cancer clinical trials. J Oncol Pract. 2016;12(6):556–63.
Engebretson A, Matrisian L, Thompson C. Patient and caregiver awareness of pancreatic cancer treatments and clinical trials. J Gastrointest Oncol. 2016;7(2):228.
Eggly S, Barton E, Winckles A, Penner LA, Albrecht TL. A disparity of words: racial differences in oncologist–patient communication about clinical trials. Health Expect. 2015;18(5):1316–26.
Dew A, Khan S, Babinski C, Michel N, Heffernan M, Stephan S, et al. Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial. Clin Trials. 2013;10(2):292–9.
Byrne MM, Tannenbaum SL, Glück S, Hurley J, Antoni M. Participation in cancer clinical trials: why are patients not participating? Med Decis Mak. 2014;34(1):116–26.
Moorcraft SY, Marriott C, Peckitt C, Cunningham D, Chau I, Starling N, et al. Patients’ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey. Trials. 2016;17(1):1–12.
Somayaji D, Cloyes KG. Cancer fear and fatalism: how African American participants construct the role of research subject in relation to clinical cancer research. Cancer Nurs. 2015;38(2):133–44.
Meng J, McLaughlin M, Pariera K, Murphy S. A comparison between Caucasians and African Americans in willingness to participate in cancer clinical trials: the roles of knowledge, distrust, information sources, and religiosity. J Health Commun. 2016;21(6):669–77.
Colon-Otero G, Smallridge RC, Solberg LA Jr, Keith TD, Woodward TA, Willis FB, et al. Disparities in participation in cancer clinical trials in the United States: a symptom of a healthcare system in crisis. Cancer. 2008;112(3):447–54.
Holmes DR, Major J, Lyonga DE, Alleyne RS, Clayton SM. Increasing minority patient participation in cancer clinical trials using oncology nurse navigation. Am J Surg. 2012;203(4):415–22.
Ghebre RG, Jones LA, Wenzel JA, Martin MY, Durant RW, Ford JG. State-of-the-science of patient navigation as a strategy for enhancing minority clinical trial accrual. Cancer. 2014;120:1122–30.
Awidi M, Al Hadidi S. Participation of black Americans in cancer clinical trials: current challenges and proposed solutions. JCO Oncol Pract. 2021;17(5):265–71.